| HOME >> BIOLOGY >> TECHNOLOGY |
Convertible debenture 2,572,873 -
------------ ------------
6,234,082 3,551,040
------------ ------------
------------ ------------
Shareholders' Equity
Capital stock 70,427,920 70,396,170
Warrants 2,550,880 6,180,690
Contributed surplus 11,312,622 7,326,962
Equity component of convertible debenture 1,427,127 -
Deficit (67,591,074) (56,159,163)
------------ ------------
18,127,475 27,744,659
------------ ------------
24,361,557 31,295,699
------------ ------------
------------ ------------
SemBioSys Genetics Inc.
Consolidated Statements of Loss, Comprehensive Loss and Deficit
(Unaudited)
-------------------------------------------------------------------------
(expressed in Canadian dollars, except shares)
Three month period ended Six month period ended
June 30, June 30, June 30, June 30,
2008 2007 2008 2007
------------ ------------ ------------ ------------
$ $ $ $
Revenue
Licensing fees
'/>"/>
| SOURCE SemBioSys Genetics Inc. Copyright©2008 PR Newswire. All rights reserved |